The continued spread of card virus related stocks were speculation-easeljs

Zika virus continues to spread related stocks was speculation Sina Hong Kong stocks fiery contest: 300 thousand bonus to recruit you to   Sina Level2:A shares of sina finance client: the most extreme Kanpan money investors are using   surprise: real-time monitoring accuracy rate is up to 86.7% of the global market trading securities times reporter Wu Jiaming is still not calm, Zhai card (the ZIKA virus has caused great concern in the market). According to overseas media reports, because of the spread of the virus is a mosquito, Brazil sent troops to clean up the breeding grounds of mosquitoes. The WHO says the virus is spreading explosively, and that 23 countries and regions have been infected in the americas. Who officials predict that 3 million to 4 million people will be infected with the virus in the coming December. The Centers for Disease Control and Prevention (CDC) have issued travel warnings to advise pregnant women to avoid reporting areas where there is a card virus. According to the latest information from the CDC, 11 states have reported cases related to travel related infections in the United states. In the overseas market, biotechnology companies related to the virus also attracted the attention of investors. It is reported that Inovio Pharmaceuticals is studying a DNA based card virus vaccine, the company plans to test the vaccine in the human body this year. Market data showed that Inovio Pharmaceuticals’s share price rose by 32% last week. In addition, the biotechnology enterprise GeneOne Life Science is working with Inovio Pharmaceuticals, for the village card, Ebola and Mers research new vaccine, the company’s stock price rose 46% last week. Gairuike ‘chief scientist of Canada and the United States joint team of scientists said that the team is developing the Zika virus vaccine may be put into emergency before the end of the year. This is much earlier than the official estimate of the United states. Earlier, U.S. officials predicted that it would take only one to two years to develop vaccines and experiments, but it would take at least 10 years to go through certification and public use. Sina statement: this news is reprinted from Sina cooperation media, Sina published this article for the purpose of transmitting more information, does not mean to agree with its views or confirm its description. This article is for reference only and does not constitute investment advice. Investors operate accordingly and take risks at their own expense. Enter Sina Financial shares] discussion 寨卡病毒持续蔓延 相关概念股遭炒作 新浪港股大赛火热招募:30万奖金等你来  新浪财经Level2:A股极速看盘 新浪财经客户端:最赚钱的投资者都在用   惊:盘中监控涨停 准确率达86.7%   证券时报记者 吴家明   全球市场依旧不平静,寨卡(ZIKA)病毒又引起市场高度关注。   据海外媒体报道,由于传播寨卡病毒的是蚊子,巴西派出军队大举清理蚊子的孳生地。世界卫生组织表示,寨卡病毒正在“爆炸式蔓延”,美洲已经有23个国家和地区受到感染。世卫组织官员预计,未来12月可能会有300万至400万人感染该病毒。美国疾控中心已经发出旅行警告,建议孕妇避免前往报告有寨卡病毒案例的地区。据美国疾控中心最新消息,美国已经有11个州报告了和旅行相关的感染寨卡病毒的案例。   而在海外市场,与寨卡病毒相关的生物科技公司也引起投资者的关注。据悉,Inovio Pharmaceuticals正在研究一个基于DNA的寨卡病毒疫苗,该公司计划于今年在人体对疫苗进行测试。市场数据显示,Inovio Pharmaceuticals的股价上周累计上涨32%。此外,生物科技企业GeneOne Life Science 正与Inovio Pharmaceuticals合作,为寨卡、埃博拉和Mers研究新疫苗,该公司股价上周更大涨46%。   加拿大和美国联合科学家团队的首席科学家盖瑞科宾格表示,该团队正在开发的寨卡病毒疫苗可能在年底前投入应急使用。这远早于美国官员估计的时间。此前有美国官员预计,研发疫苗及进行实验可能只需一到两年时间,不过若要进一步通过认证并提供公众使用,至少再需要10年时间。 新浪声明:此消息系转载自新浪合作媒体,新浪网登载此文出于传递更多信息之目的,并不意味着赞同其观点或证实其描述。文章内容仅供参考,不构成投资建议。投资者据此操作,风险自担。 进入【新浪财经股吧】讨论相关的主题文章: